MSH2 and Fanconi anemia: Genomics analysis in the above cohort revealed that in the SCPC tumors, mutations in genes related to DNA repair pathway, such as in BRCA1, BRCA2, ATM, cyclin-dependent kinase 12 (CDK12), partner and localizer of BRCA2 (PALB2), fanconi anaemia, complementation group A (FANCA), checkpoint kinase 2 (CHEK2), mutL homolog 1 (MLH1), mutS homolog 2 (MSH2), MSH3, MLH3, and MSH6 were less frequent compared to the rest cohort (p = 0.035).